The results of subgroup analyses revealed that reduced E-cadherin was predominantly associated with three-, five-year OS of patients with GC in China, Japan and Korea, as well as one-year OS of patients with GC in Japan, as illustrated in Table 3. Here, CDH1 is linked to gastric cancer.